PTEN and glioblastoma: About 85% of GBM cases show an overregulation of the RAS/MAPK and PI3K/AKT pathways linked with the loss (37% of all GBM cases) or reduction (80% of all GBM cases) of the function of phosphatase and tensin homolog (PTEN).